Education
About Us
Working with TipRanks
Follow Us
IHF - AI Analysis
Top Page
iShares U.S. Healthcare Providers ETF (IHF)
Rating:72Outperform
Price Target:
$54.00
Positive Factors
Strong Recent Performance
The ETF has shown solid gains over the past three months, reflecting positive momentum in the healthcare sector.
Focused Sector Exposure
With nearly all assets in healthcare, the ETF provides targeted exposure to a resilient and essential industry.
Reasonable Expense Ratio
The fund's expense ratio is relatively low, making it cost-effective compared to actively managed alternatives.
Negative Factors
Over-Concentration in Top Holdings
UnitedHealth alone accounts for over 22% of the portfolio, creating significant reliance on a single company’s performance.
Weak Performance from Largest Holding
UnitedHealth, the ETF's largest position, has underperformed year-to-date, potentially dragging overall returns.
Limited Geographic Diversification
The ETF is almost entirely focused on U.S. companies, offering little exposure to international markets.
IHF vs. SPDR S&P 500 ETF (SPY)
AUM806.10M
RegionNorth America
Expense Ratio0.38%
Beta0.41
IssueriShares
Inception DateMay 01, 2006
Dividend Yield0.79%
Asset ClassEquity
Index TrackedDJ US Select / Health Care Providers
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume238,995
30 Day Avg. Volume489,008
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
56.95Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering64
IHF Summary
The iShares U.S. Healthcare Providers ETF (IHF) is an investment fund that focuses on companies in the U.S. healthcare providers and services sector, such as hospitals, insurance companies, and diagnostic services. It includes well-known companies like UnitedHealth and CVS Health, which are leaders in delivering essential medical services. This ETF might appeal to investors looking for growth opportunities in the healthcare industry, which is expected to expand due to aging populations and advancements in technology. However, new investors should be aware that the ETF’s performance is closely tied to the healthcare sector, meaning it could be affected by changes in healthcare regulations or industry-specific challenges.
How much will it cost me?The iShares U.S. Healthcare Providers ETF (IHF) has an expense ratio of 0.38%, meaning you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it focuses on a specific sector and is passively managed, offering targeted exposure to healthcare providers. It’s a reasonable cost for the specialized focus it provides.
What would affect this ETF?The iShares U.S. Healthcare Providers ETF (IHF) could benefit from rising demand for healthcare services driven by an aging population and advancements in medical technology, which support growth for top holdings like UnitedHealth and CVS Health. However, potential risks include regulatory changes in the U.S. healthcare system or economic downturns that could impact healthcare spending and insurance profitability. Investors should also consider how broader market conditions, like interest rate changes, might affect the financial performance of healthcare providers and insurers.
IHF Top 10 Holdings
The iShares U.S. Healthcare Providers ETF is heavily anchored by UnitedHealth, which has been steady but faces challenges from rising medical costs that weigh on its performance. CVS Health and Humana are bright spots, with strong earnings momentum and strategic growth driving their upward trajectory. Meanwhile, Elevance Health is navigating mixed signals, balancing cost management efforts against market pressures. The fund’s focus on U.S.-based healthcare providers creates a concentrated bet on the sector’s resilience, with hospitals like HCA Healthcare adding a dose of stability amid broader uncertainty.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| UnitedHealth | 22.14% | $171.48M | $312.29B | -38.93% | 76 Outperform | |
| CVS Health | 12.28% | $95.15M | $97.35B | 35.83% | 74 Outperform | |
| Cigna | 8.32% | $64.47M | $65.96B | -21.51% | 67 Neutral | |
| HCA Healthcare | 5.27% | $40.84M | $109.23B | 30.12% | 77 Outperform | |
| Elevance Health | 4.67% | $36.21M | $71.55B | -20.66% | 68 Neutral | |
| Humana | 4.65% | $36.01M | $34.35B | 10.77% | 71 Outperform | |
| Veeva Systems | 4.62% | $35.81M | $46.72B | 36.49% | 81 Outperform | |
| Labcorp Holdings | 3.43% | $26.56M | $20.97B | 10.54% | 68 Neutral | |
| Quest Diagnostics | 3.21% | $24.89M | $19.55B | 13.51% | 70 Outperform | |
| Tenet Healthcare | 3.01% | $23.34M | $18.33B | 34.58% | 73 Outperform |
IHF Technical Analysis
Negative
―
Price Trends
49.08
Negative
46.98
Positive
48.73
Negative
Market Momentum
0.22
Positive
37.75
Neutral
13.63
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IHF, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 50.50, equal to the 50-day MA of 49.08, and equal to the 200-day MA of 48.73, indicating a bearish trend. The MACD of 0.22 indicates Positive momentum. The RSI at 37.75 is Neutral, neither overbought nor oversold. The STOCH value of 13.63 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IHF.
IHF Peer Comparison
Comparison Results
Performance Comparison
IHF
iShares U.S. Healthcare Providers ETF
48.44
-3.63
-6.97%
FXH
First Trust Health Care AlphaDEX Fund
―
―
―
RSPH
Invesco S&P 500 Equal Weight Health Care ETF
―
―
―
IHE
iShares U.S. Pharmaceuticals ETF
―
―
―
PJP
Invesco Dynamic Pharmaceuticals ETF
―
―
―
PBE
Invesco Dynamic Biotechnology & Genome ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents